Gyre Therapeutics Inc.
GYRE | NASDAQ
$4.55
-$1.86 (-29.02%)
At close: Oct 30, 2026, 4:00 PM ET
$5.00
+$0.45 (+9.90%)
Pre-market:
Nov 2, 2026, 7:00 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 29.11M | 22.52M | 37.2M | 30.56M | 29.73M | 22.06M | 27.87M | 25.49M | 25.23M | 27.17M | 27.15M | 32.04M | 29.33M | 24.93M | 28.48M | 29.17M | n/a | 794K | 2.44M | 2.3M | 1.13M | 1.47M |
Cost of Revenue | 2.21M | 1.23M | 1.74M | 1.63M | 1.15M | 894K | 1.18M | 958K | 770K | 979K | 1.25M | 1.18M | 1.08M | 1.13M | 1.36M | 1.39M | 67K | 911K | 2.45M | 2.39M | 1.18M | 1.48M |
Gross Profit | 26.9M | 21.29M | 35.45M | 28.94M | 28.58M | 21.16M | 26.7M | 24.53M | 24.46M | 26.19M | 25.9M | 30.86M | 28.25M | 23.81M | 27.12M | 27.78M | -67K | -117K | -14K | -93K | -52K | -13K |
Operating Income | -14.36M | -9.36M | 120K | 6.93M | -2.24M | 2.27M | 663K | 4.23M | 3.26M | 8.07M | -91.63M | 12.76M | 4.97M | 6.66M | 4.6M | 4.6M | -5.72M | -14.7M | -20.31M | -25.23M | -19.91M | -22.44M |
Interest Income | 740K | n/a | 509K | 200K | 941K | 200K | 346K | 523K | 350K | 328K | 326K | 283K | 251K | 184K | 167K | 283K | 85K | 2K | 4K | 7K | 11K | 17K |
Pretax Income | -14.43M | -9.24M | -66K | 7.63M | -1.58M | 4.64M | 772K | 3.93M | 6.04M | 12.48M | -100.28M | 11.19M | 5.85M | 6.27M | -1.14M | -962.3K | 51.63M | -14.54M | -20.33M | -25.24M | -19.93M | -22.44M |
Net Income | -10.61M | -8.62M | -1.72M | 3.61M | 598K | 2.7M | -99K | 1.12M | 3.53M | 7.53M | -101.01M | 3.98M | 1.85M | 2.24M | -3.48M | -3.34M | 51.63M | -14.54M | -20.33M | -25.24M | -19.93M | -22.44M |
Selling & General & Admin | 21.62M | 21.36M | 30.52M | 19.65M | 22.47M | 15.8M | 22.32M | 17.52M | 17.84M | 15.94M | 26.52M | 15.09M | 19.71M | 14.51M | 22.28M | 22.7M | 3.84M | 4.99M | 4.16M | 4.87M | 4.52M | 5.41M |
Research & Development | 19.14M | 6.74M | 4.82M | 2.36M | 8.35M | 3.1M | 3.71M | 2.78M | 3.36M | 2.18M | 4.57M | 3.01M | 3.57M | 2.64M | 6.22M | 6.28M | 1.8M | 9.59M | 16.14M | 20.27M | 15.34M | 17.01M |
Other Expenses | 502K | 2.55M | n/a | 1K | n/a | n/a | 66K | n/a | n/a | n/a | 86.44M | n/a | n/a | n/a | -5.98M | -5.8M | n/a | n/a | -20K | n/a | n/a | -17K |
Operating Expenses | 41.26M | 30.65M | 35.33M | 22.01M | 30.82M | 18.89M | 26.1M | 20.3M | 21.19M | 18.12M | 117.53M | 18.09M | 23.28M | 17.14M | 22.52M | 23.18M | 5.65M | 14.58M | 20.3M | 25.14M | 19.86M | 22.43M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 716K | 1K | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 13.75M | 14.14M | 23.82M | 15.33M | 15.2M | 10.84M | 16.86M | 13.7M | 14.41M | 12.54M | 16.46M | 13.93M | 18M | 12.77M | 15.44M | 15.79M | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 43.47M | 31.87M | 37.08M | 23.64M | 31.97M | 19.79M | 27.21M | 21.26M | 21.96M | 19.1M | 118.78M | 19.28M | 24.36M | 18.27M | 23.88M | 24.57M | 5.72M | 15.5M | 22.75M | 27.53M | 21.05M | 23.91M |
Income Tax Expense | -164K | -621K | 1.3M | 1.69M | 662K | 901K | 203K | 1.07M | 1.5M | 2.55M | 699K | 3.68M | 2.08M | 2.05M | 1.33M | 1.37M | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 100.64M | 91.32M | 91.16M | 89.12M | 89.12M | 86.42M | 85.09M | 85.64M | 85.5M | 83.27M | 76.6M | 76.6M | 69.95M | 69.95M | 63.3M | 61.05M | 62.94M | 46.79M | 31.42M | 31.38M | 31.14M | 28.39M |
Shares Outstanding (Diluted) | 100.64M | 91.34M | 102.94M | 102.7M | 89.2M | 101.97M | 102.29M | 102.64M | 104.33M | 102.59M | 76.6M | 76.6M | 70.09M | 70.09M | 63.59M | 61.05M | 62.94M | 46.79M | 31.42M | 31.38M | 31.35M | 28.39M |
EPS (Basic) | -0.12 | -0.10 | -0.02 | 0.04 | -0.02 | 0.03 | 0 | 0.01 | 0.04 | 0.09 | -1.39 | 0.05 | 0.02 | 0.04 | -0.06 | -0.05 | 0.82 | -0.31 | -0.65 | -0.80 | -0.64 | -0.79 |
EPS (Diluted) | -0.12 | -0.10 | -0.02 | 0.03 | -0.03 | 0 | 0 | 0.01 | 0.03 | 0.07 | -1.39 | 0.05 | 0.02 | 0.03 | -0.05 | -0.05 | 0.82 | -0.31 | -0.65 | -0.80 | -0.64 | -0.79 |
EBITDA | -14.37M | -8.57M | 629K | 8.28M | -1.23M | 5.17M | 1.13M | 4.4M | 6.27M | 12.9M | -4.88M | 11.39M | 6.17M | 6.56M | -1.15M | -959.27K | -5.65M | -14.59M | -20.2M | -25.15M | -19.88M | -22.39M |
EBIT | -14.43M | -9.24M | -66K | 7.63M | -2.24M | 4.64M | 663K | 3.93M | 6.04M | 12.48M | -5.19M | 11.19M | 5.85M | 6.27M | -1.38M | -1.2M | -5.72M | -14.7M | -20.33M | -25.24M | -19.93M | -22.44M |
Depreciation & Amortization | 66K | 672K | 695K | 649K | 1.01M | 535K | 471K | 474K | 238K | 415K | 308K | 202K | 318K | 286K | 231.39K | 241.56K | 67K | 113K | 115K | 85K | 45K | 45K |
Add to Watchlist
Select watchlists to add or remove GYRE